Preferred Label : Mitochondrial complex III deficiency, nuclear type 2;
Symbol : MC3DN2;
CISMeF acronym : MC3DN2;
Type : Phenotype, molecular basis known;
Description : Mitochondrial complex III deficiency nuclear type 2 is an autosomal recessive severe
neurodegenerative disorder that usually presents in childhood, but may show later
onset, even in adulthood. Affected individuals have motor disability, with ataxia,
apraxia, dystonia, and dysarthria, associated with necrotic lesions throughout the
brain. Most patients also have cognitive impairment and axonal neuropathy and become
severely disabled later in life (summary by Ghezzi et al., 2011). The disorder may
present clinically as spinocerebellar ataxia or Leigh syndrome, or with psychiatric
disturbances (Morino et al., 2014; Atwal, 2013; Nogueira et al., 2013). For a discussion
of genetic heterogeneity of mitochondrial complex III deficiency, see MC3DN1 (124000).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the tetratricopeptide repeat domain 19 gene (TTC19, 613814.0001);
Laboratory abnormalities : Decreased mitochondrial complex III activity in muscle;
Prefixed ID : #615157;
Origin ID : 615157;
UMLS CUI : C3554605;
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)